Cara Therapeutics | CARA - Actif À Court Terme





Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Alterity Therapeutics Limited AUD 37.91M 15.92M 2025-12
Cara Therapeutics USD 25.33M 6.21M 2026-03
Cassava Sciences USD 80.06M 3.67M 2026-09
Chugai Pharma JPY 1.64T 65.29B 2026-09
Cipla INR 250.61B 9.14B 2026-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 129.41M 7.88M 2026-06
CSL USD 11.85B 1000K 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
J&J USD 56.35B 3.42B 2026-09
Neurocrine Biosciences USD 2.01B 370.7M 2026-09
Pacira USD 10.3B 9.68B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
RedHill Biopharma USD 8.57M 2.05M 2026-06
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12